-- Protheragen, an ISO9001-certified supplier of pharmaceutical ingredients and specialty chemicals, today announced an expanded global supply of GLP-1 agonist APIs, including Semaglutide and Retatrutide, to meet rising demand for diabetes and obesity treatments.
Due to the rising global obesity rates and the rapidly growing clinical demand for treatments, pharmaceutical companies are increasingly turning to GLP-1 receptor agonists, which play an important role in both the treatment of type 2 diabetics and weight-management therapies. But according to the U.S. Food and Drug Administration’s (FDA) public drug shortages database, the supplies are now remaining constrained.
As a top supplier of various GLP-1 agonist APIs, Protheragen is attempting to ease the shortage. Its enhanced API portfolio now includes fully DMF-supported compounds (e.g. Semaglutide and Retatrutide), which help clients accelerate regulatory filings and shorten time to market. Additionally, other glucose-lowering APIs such as biguanides, sulfonylureas, and DPP-4 inhibitors are also available for global partners.
The Protheragen spokesperson stated, “We always focus on making sure these vital materials reach our partners without delay. And our ISO9001 certification and state licenses guarantee quality and partners know every batch is produced under the toughest quality checks.” The spokesperson added, “As an integrated supplier holding controlled substance distribution and import licenses, we maintain direct oversight of our entire supply chain. This allows us to deliver consistent, reliable batches that meet all compliance requirements time after time.”
Considering the use of Tirzepatide in clinical research application for type 2 diabetics and obesity, Protheragen also provides GMP-standard Tirzepatide accompanied by professional technical guidance, regulatory assistance, and customized logistics solutions to further speed up anti-diabetic and anti-obesity research.
Protheragen supports its partners in navigating key challenges throughout the entire drug development and production process. For the company, ensuring a reliable supply of APIs is not merely a business objective—it is a commitment to public health. Protheragen prioritizes safety, stringent quality controls, on-time delivery, and regulatory compliance to guarantee that every batch of critical APIs meets the highest industry standards.
About Protheragen
Protheragen, an ISO9001-certified supplier of pharmaceutical ingredients and specialty chemicals, is dedicated to the development and production of high-quality active pharmaceutical ingredients (APIs) and their key intermediates. Located in New York, the company has an advanced production base and an experienced research and development team, always focused on providing pharmaceutical companies with stable, reliable, and fully compliant with the regulatory requirements of high-quality products and services. With its technical and scientific research strength, it provides reliable products and solutions for the global chemical industry, including chemical products, pharmaceutical excipients, and customized synthesis services.
Contact Info:
Name: Hannah Green
Email: Send Email
Organization: Protheragen
Address: Holbrook, NY 11741, USA
Phone: 1-731-472-0755
Website: https://www.protheragen.ai/
Release ID: 89170382
Google
RSS